Trials / Active Not Recruiting
Active Not RecruitingNCT03959098
Effectiveness and Safety of Korean Medicine Treatment for Cervical Disc Herniation
Observational Study on Effectiveness and Safety of Integrative Korean Medicine Treatment for Cervical Disc Herniation With Radiculopathy
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- Jaseng Medical Foundation · Academic / Other
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A prospective observational study investigating the effectiveness and safety of integrative Korean medicine treatment in cervical disc herniation patients with neck pain or cervical radiculopathy at 4 locations of Jaseng Hospital of Korean Medicine as assessed through of pain, functional disability, work loss and quality of life patient-reported outcomes
Detailed description
This is a prospective observational study to the aim of investigating the effectiveness and safety of integrative Korean medicine treatment (generally consisting of herbal medicine, Chuna manual medicine, bee venom pharmacopuncture and pharmacopuncture, acupuncture, electroacupuncture, and cupping) in cervical disc herniation patients with neck pain or cervical radiculitis diagnosed by cervical MRI and clinical symptoms including cervical radiculopathy at 4 locations of Jaseng Hospital of Korean Medicine (Gangnam, Bucheon, Daejeon, Haeundae) as assessed through of pain, functional disability, work loss, and quality of life patient-reported outcomes with a 5-year follow-up period
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Herbal medicine | Herbal medicine will be administered in water-based decoction (120ml) and dried powder (2g) form (Ostericum koreanum,Eucommia ulmoides, canthopanax sessiliflorus, Achyranthes japonica, Psoralea corylifolia, aposhnikovia divaricata, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, Glycinemax, Atractylodes japonica) at the physician's discretion. |
| PROCEDURE | Chuna manual medicine | Chuna is a Korean manual therapy directed at the spine and joints that incorporates various spinal manual medicine techniques for joint mobilization involving highvelocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement. Chuna manual medicine will be administered to the pelvic, lumbar, thoracic, and cervical vertebrae at the physician's discretion. |
| PROCEDURE | Bee venom pharmacopuncture | Bee venom pharmacopuncture will be administered only after confirming a negative response to hypersensitivity skin test. Diluted bee venom saline:bee venom ratio, 10,000:1) filtered for allergens will usually be injected at 4-5 acupoints proximal to the dysfunctional site at the physician's discretion. Each acupuncture point will be injected to a total of 0.5-1 cc using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, hinchang medical co., Korea). |
| PROCEDURE | Pharmacopuncture | Pharmacopuncture consisting of select herbal ingredients will be dministered at Hyeopcheok (Huatuo Jiaji, EX B2), Ah-shi points and local acupuncture points using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea) at the physician's discretion. |
| PROCEDURE | Acupuncture | Acupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points. |
| PROCEDURE | Electroacupuncture | Electroacupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points. |
| PROCEDURE | Cupping | Cupping treatment will be administered at 1-2 points using mainly proximal acupuncture points and Ah-shi points. |
| PROCEDURE | Other intervention(s) | Patients will be allowed any other additional intervention(s) as deemed necessary regardless of type or dose, and patterns of use will be investigated and recorded as a pragmatic clinical study. |
Timeline
- Start date
- 2019-06-24
- Primary completion
- 2022-01-28
- Completion
- 2027-12-01
- First posted
- 2019-05-22
- Last updated
- 2025-12-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03959098. Inclusion in this directory is not an endorsement.